Evidence memo / Longevity & metabolic aging

SHLP mitochondrial-derived peptides

Also: small humanin-like peptides · SHLP1-6 · mitochondrial-derived peptides

SHLPs are a family of tiny peptides encoded within mitochondrial DNA, studied as natural signals that may influence metabolism, cell survival, and aging. The evidence is preclinical, from cells, animals, and human association studies, with no clinical trials of SHLPs as a treatment. The Watchlist boundary is keeping this to the basic biology and not letting an interesting aging-research story become a product claim.

No human data yetPreclinicalSafety / regulatory watch

The verdict

Our read at a glance.

Whether the mitochondrial-derived SHLP peptides, which show metabolic and protective effects in the lab, support any of the anti-aging or metabolic benefits attributed to them.

The signal
In cells and animals, several SHLPs improve insulin sensitivity, protect cells from stress, and influence metabolism, and human studies have linked their levels to aging and disease. None of this has been tested as a treatment in people.
The unknown
Whether giving SHLPs to people does anything useful or is safe, since the work so far is basic biology and association, not clinical treatment.
Our read
Real mitochondrial biology, not a supplement you can buy with any evidence behind it. SHLPs matter for understanding aging and metabolism, but there are no human treatment trials, so product claims run far ahead of the science.

The mechanism

How it works.

SHLPs are a family of small peptides (SHLP1 through SHLP6) encoded by a short open reading frame inside mitochondrial DNA, the same region that encodes humanin. They are thought to act as signals that mitochondria send to the rest of the cell, with reported effects on insulin signaling, protection of cells under stress, and metabolic regulation, in some cases by binding cell-surface receptors and shifting downstream survival pathways. These effects come from cells, animals, and human blood-level associations, and giving SHLPs to people has not been tested, so it is not established that supplementing them changes anything in humans.

Safety & regulatory boundary

The consequential part.

SHLPs are a research subject, not an approved or clinically tested therapy. There are no human trials of SHLP supplementation, no established dose, and no safety data in people. Any product sold as an SHLP peptide is unproven and outside any regulatory approval.

What's next

What we're watching.

Whether SHLP biology translates into any human intervention study, and how their levels track with metabolic and age-related disease.

Context

Why this is discussed.

SHLPs come from a surprising finding, that the mitochondria themselves make signaling peptides linked to metabolism and longevity, which feeds anti-aging interest.

The evidence base

12 cited references.

Indexed literature (PubMed)12

MOTS-c reduces myostatin and muscle atrophy signaling

Kumagai H et al. · Am J Physiol Endocrinol Metab · 2021

Mitochondrial-derived peptides in energy metabolism

Merry TL et al. · Am J Physiol Endocrinol Metab · 2020

The emerging role of mitochondrial derived peptide humanin in the testis

Lue Y et al. · Biochim Biophys Acta Gen Subj · 2021

Keep reading

Related published memos.